Skip to content

Connect - Discover - Share
  • Home
  • Products
    • Coremine Vitae
    • Coremine Medical
    • Coremine Oncology
    • Coremine Platform
  • News
  • About Us
    • Company Background
    • Board of Directors
    • Management Team
    • Partners
  • Contact

Connect - Discover - Share
  • Home
  • Products
    • Coremine Vitae
    • Coremine Medical
    • Coremine Oncology
    • Coremine Platform
  • News
  • About Us
    • Company Background
    • Board of Directors
    • Management Team
    • Partners
  • Contact

Coremine Vitae applied on neuro diseases

  • February 2020June 2020

PubGene has conducted a first Coremine Vitae within the neuro diseases. We successfully provided an epilepsy patient with information on disease characteristics and drugs.   

PrevPreviousCoremine Medical upgrade
NextPubGene received the Horizon 2020 Seal of ExcellenceNext

Recent Posts

  • Why Google, When You Can Coremine – Lecture by Jimita Toraskar
  • Dr. Jimita Toraskar interviewed by The Future of Health.care group
  • Pubgene’s digital health COREMINE Vitae™ obtained CE-mark
  • Pre-study on the use of COREMINE™ Medical AS decision support for Covid-19
  • Dialogue with Norwegian health authorities on COVID-19

Archives

  • September 2020
  • June 2020
  • May 2020
  • March 2020
  • February 2020
  • January 2020
  • November 2019
  • August 2019
  • June 2019
  • May 2019
  • April 2019
  • February 2019

Contact info

PubGene AS – Klaus Torgårds Vei 3 – 0372 Oslo – Norway

info@pubgene.com

© Pubgene 2020